Key Findings:  The goal of this pilot study was to assess the feasibility of conducting a randomized controlled trial of cannabidiol in treating children with severe behavioral and intellectual disabilities. Overall the efficacy signal favored active drug.
Type of Study:  Double Blind Clinical Trial
Study Sample Size:  8
Study Result:  Positive
Study Location(s):  Australia
Year of Pub:  2021
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Cannabis Flower derived
Chemotype:  Chemotype III